Regorafenib superior to lomustine in randomized phase 2 trial for reGBM - Hallo friendsTOP POLENNEWS, In the article you read this time with the title Regorafenib superior to lomustine in randomized phase 2 trial for reGBM, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cultur, Article economic, Article health, Article news, Article politique, Article sport, We write this you can understand. Alright, good read.

Title : Regorafenib superior to lomustine in randomized phase 2 trial for reGBM
link : Regorafenib superior to lomustine in randomized phase 2 trial for reGBM

Regorafenib superior to lomustine in randomized phase 2 trial for reGBM

http://sci-hub.tw/10.1016/S1470-2045(18)30675-2

This is newsworthy because I expect trials like this to fail in GBM, and I'm very biased against single agent kinase inhibitor trials for GBM, but this one showed regorafenib to actually be superior to lomustine in a randomized phase 2 trial.

Thus Article Regorafenib superior to lomustine in randomized phase 2 trial for reGBM

That's an article Regorafenib superior to lomustine in randomized phase 2 trial for reGBM This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article Regorafenib superior to lomustine in randomized phase 2 trial for reGBM with the link address https://polennews.blogspot.com/2018/12/regorafenib-superior-to-lomustine-in.html

Tweet

Subscribe to receive free email updates: